Concepedia

Cynthia J. Bucher

CJ

Statistics

Publications

8

Citations

342

H-Index

8

Active since

2004

Affiliations

Moffitt Cancer Center(Current)

Yale University

University of South Florida

University of Washington

University of Chicago

Cynthia J. Bucher is an author at Moffitt Cancer Center specializing in pharmacology, pharmacy, and enzyme inhibition.

Publications per year

2004–2012

8

Publications

8

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)

Thomas F. Gajewski, April K.S. Salama, Donna Niedzwiecki et al. · Journal of Translational Medicine · 2012 · 79 citations · Full text

, , +15

Blockade of Protein Geranylgeranylation Inhibits Cdk2-Dependent p27<sup>Kip1</sup> Phosphorylation on Thr187 and Accumulates p27<sup>Kip1</sup> in the Nucleus: Implications for Breast Cancer Therapy

Aslamuzzaman Kazi, Adam Carie, Michelle A. Blaskovich et al. · Molecular and Cellular Biology · 2009 · 62 citations · Full text

, , +17

Synthesis and evaluation of potent, highly-selective, 3-aryl-piperazinone inhibitors of protein geranylgeranyltransferase-I

Hairuo Peng, Dora Carrico, Van Thai et al. · Organic & Biomolecular Chemistry · 2006 · 52 citations

, , +16

Structure-Based Design and Synthesis of Potent, Ethylenediamine-Based, Mammalian Farnesyltransferase Inhibitors as Anticancer Agents

Steven Fletcher, Erin P. Keaney, Christopher G. Cummings et al. · Journal of Medicinal Chemistry · 2010 · 48 citations · Full text

, , +15

In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability

Dora Carrico, Junko Ohkanda, Howard Kendrick et al. · Bioorganic & Medicinal Chemistry · 2004 · 44 citations · Full text

, , +16

1–5 of 8